2022-12-13 20:31:31
每經AI快訊, 偉(wei)(wei)星(xing)(xing)股(gu)(gu)份公(gong)(gong)告,參股(gu)(gu)子公(gong)(gong)司浙江(jiang)偉(wei)(wei)星(xing)(xing)光(guang)學股(gu)(gu)份有限(xian)公(gong)(gong)司(簡稱“偉(wei)(wei)星(xing)(xing)光(guang)學”)已向浙江(jiang)證監局提交首次(ci)公(gong)(gong)開發(fa)(fa)行股(gu)(gu)票(piao)輔導備案材(cai)料并(bing)獲得受理,輔導機構為安信證券。偉(wei)(wei)星(xing)(xing)光(guang)學專業(ye)從事眼用光(guang)學鏡片的研(yan)發(fa)(fa)、生產(chan)和銷(xiao)售。截至公(gong)(gong)告披露日,公(gong)(gong)司持有偉(wei)(wei)星(xing)(xing)光(guang)學20.87%的股(gu)(gu)份。
特別提醒:如果我們使用了您的圖片,請作者與本站聯系索取稿酬。如您不希望作(zuo)品出現在本站,可聯系我們(men)要求撤下您的作(zuo)品。
歡迎關(guan)注(zhu)每日經濟新聞APP